We found increased MCP-1, CD11b and GFAP immunoreactivity in hypercholesterolemic ischemic brains, suggesting that MCP-1 production and microglia and astrocyte activation are involved in the promotion of hyperlipidemia-induced inflammation and injury in the ischemic brain. This evidence concerns the gene ITGAM and hyperlipidemia.